1
Acquired
immune deficiency syndrome or acquired immunodeficiency
syndrome (AIDS or Aids) is a collection of symptoms
and
infections resulting from the specific damage to the immune system
caused by
the human immunodeficiency virus (HIV).
The late stage of the condition
leaves individuals prone to opportunistic infections and tumors.
Although
treatments for AIDS and HIV exist to slow the virus's progression,
there is no
known cure. HIV is transmitted through direct contact of a mucous
membrane or
the bloodstream with a bodily fluid containing HIV, such as blood,
semen,
vaginal fluid, preseminal fluid, and breast milk. This transmission can
come in
the form of anal, vaginal or oral sex, blood transfusion, contaminated
hypodermic needles, exchange between mother and baby during pregnancy,
childbirth, or breastfeeding, or other exposure to one of the above
bodily
fluids.
AIDS is
the most severe manifestation of infection with HIV. HIV is a
retrovirus that primarily infects vital components of the human immune
system
such as CD4+ T cells (a subset of T cells), macrophages and
dendritic cells.
In the
absence of antiretroviral therapy, the median time of progression
from HIV infection to AIDS is nine to ten years, and the median
survival time
after developing AIDS is only 9 months. However, the rate of clinical
disease
progression varies widely between individuals, from two weeks up to 20
years.
Diagnosis
Stage I: HIV
infection is asymptomatic and not categorized as AIDS
Stage II:
includes minor mucocutaneous manifestations and recurrent upper
respiratory
tract infections
Stage
III:
includes unexplained chronic diarrhea for longer than a month, severe
bacterial
infections and pulmonary tuberculosis
Stage IV:
includes toxoplasmosis of the brain, candidiasis of the esopfagus,
trachea,
bronchi or lungs and Kaposi’s sarcoma; these diseases are indicators of
AIDS
HIV test
Many people are unaware that they
are infected with HIV. Less than 1% of the sexually active urban
population in Africa has been tested,
and this proportion is even lower
in rural populations. Furthermore, only 0.5% of pregnant women
attending urban
health facilities are counseled, tested or receive their test results.
Again,
this proportion is even lower in rural health facilities. Therefore,
donor
blood and blood products used in medicine and medical research are
screened for
HIV. Typical HIV tests, including the HIV enzyme immunoassay and the
Western
blot assay, detect HIV antibodies in serum, plasma, oral fluid, dried
blood
spot or urine of patients. However, the window period (the time between
initial
infection and the development of detectable antibodies against the
infection)
can vary. This is why it can take 3–6 months to seroconvert and test
positive.
Commercially available tests to detect other HIV antigens, HIV-RNA, and
HIV-DNA
in order to detect HIV infection prior to the development of detectable
antibodies are available. For the diagnosis of HIV infection these
assays are
not specifically approved, but are nonetheless routinely used in
developed
countries.
Symptoms and complications
The symptoms of AIDS are
primarily the result of conditions that do not normally develop in
individuals
with healthy immune systems. Most of these conditions are infections
caused by
bacteria, viruses, fungi and parasites that are normally controlled by
the
elements of the immune system that HIV damages. Opportunistic
infections are
common in people with AIDS. HIV affects nearly every organ system.
People with
AIDS also have an increased risk of developing various cancers such as
Kaposi's
sarcoma, cervical cancer and cancers of the immune system known as
lymphomas.
Additionally,
people with AIDS often have systemic symptoms of infection
like fevers, sweats (particularly at night), swollen glands, chills,
weakness,
and weight loss. After the diagnosis of AIDS is made, the current
average
survival time with antiretroviral therapy (as of 2005) is estimated to
be more
than 5 years, but because new treatments continue to be developed and
because
HIV continues to evolve resistance to treatments, estimates of survival
time
are likely to continue to change. Without antiretroviral therapy, death
normally occurs within a year. Most patients die from opportunistic
infections
or malignancies associated with the progressive failure of the immune
system.
The rate of clinical disease
progression varies widely between individuals and has been shown to be
affected
by many factors such as host susceptibility and immune function health
care and
co-infections, as well as factors relating to the viral strain. The
specific
opportunistic infections that AIDS patients develop depend in part on
the
prevalence of these infections in the geographic area in which the
patient
lives.
1
Transmission
and prevention
The three
main transmission routes of HIV are sexual contact, exposure to
infected body fluids or tissues, and from mother to fetus or child
during
perinatal period. It is possible to find HIV in the saliva, tears, and
urine of
infected individuals, but there are no recorded cases of infection by
these
secretions, and the risk of infection is negligible.
Never use needles or
syringes that have been used by
others. When receiving medical attention, always insist that unused,
disposable
equipment or fully sterilized material is used. If you do need an
injection,
ask to see the syringe unwrapped in front of you, or better still take
a needle
and syringe pack with you overseas - it is a cheap insurance package
against
infection with HIV. Never use another person's razor or toothbrush.
Don't have
parts of your body pierced, or allow yourself to be tattooed.
Treatment
There is currently no vaccine or
cure for HIV or AIDS. The only known
methods of prevention are based on avoiding exposure to the virus or,
failing
that, an antiretroviral treatment directly after a highly significant
exposure,
called post-exposure prophylaxis (PEP). PEP has a very demanding four
week
schedule of dosage. It also has very unpleasant side effects including
diarrhea, malaise, nausea and fatigue.
Epidemiology
AIDS has
killed more than 25 million people since it was first recognized
in 1981, making it one of the most destructive epidemics in recorded
history.
Globally,
between 33.4 and 46 million people currently live with HIV. In
2005, between 3.4 and 6.2 million people were newly infected and
between 2.4
and 3.3 million people with AIDS died, an
increase from 2003 and the highest number since 1981.
Sub-Saharan
Africa remains by far the
worst affected region, with an estimated 21.6 to 27.4 million people
currently
living with HIV. Two million [1.5–3.0 million] of them are children
younger
than 15 years of age.
Stigma
AIDS stigma exists around the
world in a variety of ways, including ostracism, rejection,
discrimination and
avoidance of HIV infected people; compulsory HIV testing without prior
consent
or protection of confidentiality; violence against HIV infected
individuals or
people who are perceived to be infected with HIV; and the quarantine of
HIV
infected individuals. Stigma-related violence or the fear of violence
prevents
many people from seeking HIV testing, returning for their results, or
securing
treatment, possibly turning what could be a manageable chronic illness
into a
death sentence and perpetuating the spread of HIV.
Often,
AIDS stigma is expressed in conjunction with one or more other
stigmas, particularly
those
associated with homosexuality, bisexuality, promiscuity, and
intravenous drug use.
Those
most likely to hold misconceptions about HIV transmission and to
harbor HIV/AIDS stigma are less educated people and people with high
levels of
religiosity or conservative political
ideology.
|